New England Eye Center, Tufts Medical Center, Boston, Massachusetts, USA.
Am J Ophthalmol. 2011 Oct;152(4):663-8. doi: 10.1016/j.ajo.2011.03.008. Epub 2011 Jun 25.
To understand the relationship between choroidal thickness and various disease factors in patients with age-related macular degeneration (AMD) using spectral-domain optical coherence tomography.
Cross-sectional, retrospective analysis.
Fifty-seven eyes of 47 patients with wet and dry AMD seen between November 2009 and January 2010 at the New England Eye Center, Boston, Massachusetts, were analyzed. Choroidal thickness was measured by 2 independent observers at 11 sites with high-definition horizontal 1-line raster scans through the foveal center. A retrospective chart review was performed to obtain data concerning duration of disease, number of intravitreal anti-vascular endothelial growth factor injections, visual acuity, lens status, and concomitant retinal pathologic features. The Pearson correlation and Student t test were used for statistical analysis for assessment of choroidal thickness changes in wet and dry AMD.
The choroid in eyes with wet and dry AMD demonstrated a wide range of thicknesses above and below the normal mean (range, 77.5 to 399.5 μm; standard deviation [SD], 90.2). Nearly one third (33.3%) of the eyes with AMD measured less than 1 SD below the mean. Eyes with wet AMD demonstrated a mean subfoveal choroidal thickness of 194.6 μm (SD, 88.4; n = 40) compared with 213.4 μm (SD, 92.2; n = 17) in the dry AMD group. The choroidal thickness in eyes with dry AMD was correlated inversely with age (r = -0.703; P = .002); however, analysis of the number of intravitreal anti-vascular endothelial growth factor injections, number of years of disease, and visual acuity failed to demonstrate any significant correlations with choroidal thickness.
This study demonstrated that choroidal thickness can be measured by spectral-domain optical coherence tomography and that variable choroidal thickness exists among patients with the clinical diagnosis of wet and dry AMD. However, it is unclear at this time why in some eyes, choroidal thickness either increases or decreases with the disease. Further studies need to be carried out to understand the significance of choroidal thickness with respect to visual function and disease progression over time.
使用频域光相干断层扫描(OCT)了解年龄相关性黄斑变性(AMD)患者脉络膜厚度与各种疾病因素之间的关系。
横断面、回顾性分析。
对 2009 年 11 月至 2010 年 1 月在马萨诸塞州波士顿新英格兰眼中心就诊的 47 例 57 只湿性和干性 AMD 患者的眼睛进行分析。通过穿过中心凹的高分辨率水平 1 线光栅扫描,由 2 位独立观察者在 11 个部位测量脉络膜厚度。回顾性图表审查以获取有关疾病持续时间、玻璃体内抗血管内皮生长因子注射次数、视力、晶状体状态和并发视网膜病理特征的数据。使用 Pearson 相关和学生 t 检验进行统计分析,以评估湿性和干性 AMD 脉络膜厚度的变化。
湿性和干性 AMD 患者的脉络膜厚度在正常均值以上和以下均有很大差异(范围:77.5 至 399.5μm;标准差 [SD],90.2)。将近三分之一(33.3%)的 AMD 眼测量值低于均值 1 SD 以下。湿性 AMD 眼的平均中心凹下脉络膜厚度为 194.6μm(SD,88.4;n=40),而干性 AMD 组为 213.4μm(SD,92.2;n=17)。干性 AMD 眼的脉络膜厚度与年龄呈负相关(r=-0.703;P=0.002);然而,对玻璃体内抗血管内皮生长因子注射次数、疾病年限和视力的分析未能显示与脉络膜厚度有任何显著相关性。
本研究表明,频域 OCT 可测量脉络膜厚度,并且在具有湿性和干性 AMD 临床诊断的患者中存在可变的脉络膜厚度。然而,目前尚不清楚为什么在某些眼中,脉络膜厚度会随着疾病的发展而增加或减少。需要进一步的研究来了解脉络膜厚度与视觉功能和随时间推移的疾病进展之间的关系。